ブリオナ・テイラーへの銃撃事件 - Wikipedia
In ufology, the Taylor Incident, a.k.a. Livingston Incident or Dechmont Woods Encounter is the name given to claims of sighting an extraterrestrial spacecraft on Dechmont Law in Livingston, West Lothian, Scotland in 1979 by forester Robert "Bob" Taylor (1919–2007).
When Taylor returned home from a trip to Dechmont Law dishevelled, his clothes torn and with grazes to his chin and thighs, he claimed he had encountered a "flying dome" which tried to pull him aboard. Due to his injuries, the police recorded the matter as a common assault and the incident is popularly promoted as the "only example of an alien sighting becoming the subject of a criminal investigation".[1][2]
Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston Scotland, Solna Sweden and Vienna Austria, with other offices in France, Canada and the United States.[1][2][3]
Valneva was founded in 2013 through the merger of Austrian company Intercell and French company Vivalis SA.[4][5] It has been listed since 28 May 2013 on the Euronext Paris in Paris and used to be listed on the Vienna Stock Exchange.
Products
Vaccines marketed by Valneva include Ixiaro, a vaccine against Japanese encephalitis (approved in Europe, America and Australia)[6] and Dukoral, a vaccine against cholera (approved in Europe, America and Australia).[7]
Some of its candidates have failed in clinical trials: VLA43, a therapeutic vaccine against Pseudomonas aeruginosa,[8] V710, a therapeutic vaccine against Staphylococcus aureus (in collaboration with Merck),[9] and IC41, therapeutic vaccine against hepatitis C.[10]
COVID-19 vaccine development
Valneva has developed a candidate inactivated whole virus vaccine against COVID-19, VLA2001[11] derived from its Ixiaro vaccine, which is undergoing a Phase 1/2 trial in the United Kingdom.[12][13] The Phase 1/2 trial has 150 participants testing three dose levels for safety, tolerability, and immunogenicity. The trial is expected to be complete by 15 February 2021, with full reporting completed by August 2021.[14]
Valneva has reached an agreement with the UK government to provide up to 100 million doses to be manufactured at its facility in Livingston, Scotland. The UK government has pre-ordered 60 million doses.[11][12] The trials are being supported by the UK National Institute for Health Research and four British universities.[14] Due to government support, Valneva will progress immediately into Phase 3 trials and develop production capacity before the full evaluation of the Phase 1/2 trial, rather than the traditional slower sequential approach which has lower financial risk.[15]
The company manufacturing facility in Livingston, Scotland produces the VLA2001 vaccine.[16][17]
2008/08/11 — 去年の熊本地震などの影響で、日本脳炎などのワクチンが一部の医療機関で入手しづらくなっていることを受けて、6日、患者団体などが東京都内の街頭を行進し、国が安定供給に向けた体制を整えるよう訴えました。6日 ...
、、、（爆ｗｗｗｗｗｗｗｗｗｗ
3 件のコメント:
吉田といっしょでTaylor姓にろくなやつはいない？
あっ。。。James Taylorは好きw
平 → ヒラ → タイラ
タイラとテイラーが似ているのは何故なんでしょうかｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗ
言霊コワイｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗ
こんなに紳士服チェーン店が存在するの、日本だけですものね。
誰が買ってるんだか、ホントに儲かってるんだか、知りませんが。
さすがTaylor & 日本脳炎の国 wwwww
コメントを投稿